EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons

William T Barham, Marshall Patrick Stagg, Rula Mualla, Michael DiLeo, Sagar Kansara iD

Cancers · 05.01.2025 · 17 (1) · 144

DOI: 10.3390/cancers17010144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 05.01.2025. Verfasst von William T Barham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, New Orleans, LA 71103, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head and neck cancer is a deadly disease with over 500,000 cases annually worldwide. Metastatic head and neck cancer accounts for a large proportion of the mortality associated with this disease. Many advances have been made in our understanding of the mechanisms of metastasis. The application of immunotherapy to locally recurrent or metastatic head and neck cancer has not only improved oncologic outcomes but has also provided valuable insights into the mechanisms of immune evasion and ultimately treatment failure.

Objectives

This review paper will review our current understanding of biological mechanisms of treatment failure and metastasis. Published and ongoing clinical trials in the management of metastatic head and neck cancer will also be summarized.

Methods

A narrative review was conducted to address the current understanding of the mechanisms of treatment failure and current treatment paradigms in recurrent and metastatic head and neck carcinoma.

Conclusions

Our understanding of treatment failure in this disease is rapidly evolving. Immunotherapy represents a valuable new tool in the fight against recurrent and metastatic head and neck squamous cell carcinoma. Integrating patient and tumor specific data via artificial intelligence and deep learning will allow for a precision oncology approach, thereby achieving better prognostication and management of patients with this deadly disease.

Schlagwörter

Stichwörter der Autor:innen

immunotherapymetastatic head and neck cancersquamous cell carcinoma

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, New Orleans, LA 71103, USA.
  • Department of Oncology, Our Lady of the Lake Regional Medical Center, Baton Rouge, LA 70809, USA.

ORCID-Profile: Sagar Kansara

Zitieren

APA

Barham, W. T., Stagg, M. P., Mualla, R., DiLeo, M., & Kansara, S. (2025). Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons. Cancers, 17(1), 144. https://doi.org/10.3390/cancers17010144

Vancouver

Barham WT, Stagg MP, Mualla R, DiLeo M, Kansara S. Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons. Cancers. 2025;17(1):144. doi:10.3390/cancers17010144

BibTeX
@article{Barham2025,
  author = {Barham, William T and Stagg, Marshall Patrick and Mualla, Rula and DiLeo, Michael and Kansara, Sagar},
  title = {Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {1},
  pages = {144},
  doi = {10.3390/cancers17010144}
}
Kostenlos starten →